TALPHERA, INC. Operating Expenses
TALPHERA, INC. (TLPH) reported Operating Expenses of $15.47 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-03-16
- TALPHERA, INC. operating expenses for the quarter ending 2019-12-31 was $15.47M, a 33.45% increase year-over-year.
- TALPHERA, INC. operating expenses for the quarter ending 2019-09-30 was $14.14M, a 45.72% increase year-over-year.
- TALPHERA, INC. operating expenses for the quarter ending 2019-06-30 was $14.30M, a 79.43% increase year-over-year.
- TALPHERA, INC. operating expenses for the quarter ending 2019-03-31 was $12.58M, a 46.11% increase year-over-year.
- TALPHERA, INC. operating expenses for fiscal 2018 was $37.88M, a 18.85% decline from fiscal 2017.
- TALPHERA, INC. operating expenses for fiscal 2017 was $46.68M, a 5.35% decline from fiscal 2016.
- TALPHERA, INC. operating expenses for fiscal 2016 was $49.31M, a 25.75% increase from fiscal 2015.
- TALPHERA, INC. operating expenses for fiscal 2015 was $39.22M, a 8.51% decline from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 72 month | Operating Expenses 75 month | Operating Expenses 78 month | Operating Expenses 81 month | Operating Expenses 84 month | Operating Expenses 87 month | Operating Expenses 90 month | Operating Expenses 93 month | Operating Expenses 96 month | Operating Expenses 99 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $15.47M 10-K · filed 2020-03-16 | $29.61M derived: sum of 2 quarters · filed 2020-03-16 | $43.91M derived: sum of 3 quarters · filed 2020-03-16 | $56.49M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2019-09-30 | $14.14M 10-K · filed 2020-03-16 | $28.44M derived: sum of 2 quarters · filed 2020-03-16 | $41.03M derived: sum of 3 quarters · filed 2020-03-16 | $52.62M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2019-06-30 | $14.30M 10-K · filed 2020-03-16 | $26.89M derived: sum of 2 quarters · filed 2020-03-16 | $38.48M derived: sum of 3 quarters · filed 2020-03-16 | $48.18M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2019-03-31 | $12.58M 10-K · filed 2020-03-16 | $24.17M derived: sum of 2 quarters · filed 2020-03-16 | $33.88M derived: sum of 3 quarters · filed 2020-03-16 | $41.85M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2018-12-31 | $11.59M 10-K · filed 2020-03-16 | $21.30M derived: sum of 2 quarters · filed 2020-03-16 | $29.27M derived: sum of 3 quarters · filed 2020-03-16 | $37.88M 10-K · filed 2019-03-07 | ||||||||||
| 2018-09-30 | $9.71M 10-K · filed 2020-03-16 | $17.68M derived: sum of 2 quarters · filed 2020-03-16 | $26.29M 10-Q · filed 2018-11-05 | $34.84M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2018-06-30 | $7.97M 10-K · filed 2020-03-16 | $16.58M 10-Q · filed 2018-08-02 | $25.13M derived: sum of 3 quarters · filed 2020-03-16 | $35.48M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2018-03-31 | $8.61M 10-K · filed 2020-03-16 | $17.16M derived: sum of 2 quarters · filed 2020-03-16 | $27.51M derived: sum of 3 quarters · filed 2020-03-16 | $40.11M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2017-12-31 | $8.55M 10-K · filed 2019-03-07 | $18.89M derived: sum of 2 quarters · filed 2019-03-07 | $31.50M derived: sum of 3 quarters · filed 2019-03-07 | $46.68M 10-K · filed 2019-03-07 | ||||||||||
| 2017-09-30 | $10.35M 10-K · filed 2019-03-07 | $22.95M derived: sum of 2 quarters · filed 2019-03-07 | $38.13M 10-Q · filed 2018-11-05 | $51.70M derived: sum of 4 quarters · filed 2019-03-07 | ||||||||||
| 2017-06-30 | $12.60M 10-K · filed 2019-03-07 | $27.78M 10-Q · filed 2018-08-02 | $41.35M derived: sum of 3 quarters · filed 2019-03-07 | $52.70M derived: sum of 4 quarters · filed 2019-03-07 | ||||||||||
| 2017-03-31 | $15.18M 10-K · filed 2019-03-07 | $28.75M derived: sum of 2 quarters · filed 2019-03-07 | $40.10M derived: sum of 3 quarters · filed 2019-03-07 | $52.95M derived: sum of 4 quarters · filed 2019-03-07 | ||||||||||
| 2016-12-31 | $13.57M 10-K · filed 2018-03-09 | $24.91M derived: sum of 2 quarters · filed 2018-03-09 | $37.77M derived: sum of 3 quarters · filed 2018-03-09 | $49.31M 10-K · filed 2019-03-07 | ||||||||||
| 2016-09-30 | $11.34M 10-K · filed 2018-03-09 | $24.19M derived: sum of 2 quarters · filed 2018-03-09 | $35.74M 10-Q · filed 2017-11-09 | $45.01M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||
| 2016-06-30 | $12.85M 10-K · filed 2018-03-09 | $24.40M 10-Q · filed 2017-08-02 | $33.67M derived: sum of 3 quarters · filed 2018-03-09 | $41.99M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||
| 2016-03-31 | $11.55M 10-K · filed 2018-03-09 | $20.81M derived: sum of 2 quarters · filed 2018-03-09 | $29.14M derived: sum of 3 quarters · filed 2018-03-09 | $39.18M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||
| 2015-12-31 | $9.27M 10-K · filed 2017-03-03 | $17.59M derived: sum of 2 quarters · filed 2017-03-03 | $27.64M derived: sum of 3 quarters · filed 2017-03-03 | $39.22M 10-K · filed 2018-03-09 | ||||||||||
| 2015-09-30 | $8.32M 10-K · filed 2017-03-03 | $18.37M derived: sum of 2 quarters · filed 2017-03-03 | $29.95M 10-Q · filed 2016-11-02 | $41.96M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2015-06-30 | $10.05M 10-K · filed 2017-03-03 | $21.63M 10-Q · filed 2016-07-29 | $33.63M derived: sum of 3 quarters · filed 2017-03-03 | $43.53M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2015-03-31 | $11.58M 10-K · filed 2017-03-03 | $23.59M derived: sum of 2 quarters · filed 2017-03-03 | $33.48M derived: sum of 3 quarters · filed 2017-03-03 | $45.81M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2014-12-31 | $12.01M 10-K · filed 2016-03-07 | $21.90M derived: sum of 2 quarters · filed 2016-03-07 | $34.23M derived: sum of 3 quarters · filed 2016-03-07 | $42.87M 10-K · filed 2017-03-03 | ||||||||||
| 2014-09-30 | $9.89M 10-K · filed 2016-03-07 | $22.23M derived: sum of 2 quarters · filed 2016-03-07 | $30.86M 10-Q · filed 2015-11-03 | $38.48M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2014-06-30 | $12.33M 10-K · filed 2016-03-07 | $20.97M 10-Q · filed 2015-08-04 | $28.59M derived: sum of 3 quarters · filed 2016-03-07 | $37.45M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2014-03-31 | $8.64M 10-K · filed 2016-03-07 | $16.26M derived: sum of 2 quarters · filed 2016-03-07 | $25.12M derived: sum of 3 quarters · filed 2016-03-07 | $33.30M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2013-12-31 | $7.62M 10-K · filed 2015-03-13 | $16.48M derived: sum of 2 quarters · filed 2015-03-13 | $24.66M derived: sum of 3 quarters · filed 2015-03-13 | $36.17M 10-K · filed 2016-03-07 | ||||||||||
| 2013-09-30 | $8.86M 10-K · filed 2015-03-13 | $17.04M derived: sum of 2 quarters · filed 2015-03-13 | $28.55M 10-Q · filed 2014-11-10 | $38.25M derived: sum of 4 quarters · filed 2015-03-13 | $147.37M 10-Q · filed 2013-11-05 | |||||||||
| 2013-06-30 | $8.18M 10-K · filed 2015-03-13 | $19.69M 10-Q · filed 2014-08-11 | $29.39M derived: sum of 3 quarters · filed 2015-03-13 | $37.75M derived: sum of 4 quarters · filed 2015-03-13 | $138.51M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | $11.51M 10-K · filed 2015-03-13 | $21.21M derived: sum of 2 quarters · filed 2015-03-13 | $29.57M derived: sum of 3 quarters · filed 2015-03-13 | $36.74M derived: sum of 4 quarters · filed 2015-03-13 | $130.33M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $9.70M 10-K · filed 2014-03-17 | $18.06M derived: sum of 2 quarters · filed 2014-03-17 | $25.23M derived: sum of 3 quarters · filed 2014-03-17 | $32.11M 10-K · filed 2015-03-13 | $118.82M 10-K · filed 2013-03-12 | |||||||||
| 2012-09-30 | $8.36M 10-K · filed 2014-03-17 | $15.53M derived: sum of 2 quarters · filed 2014-03-17 | $22.40M 10-Q · filed 2013-11-05 | $28.82M derived: sum of 4 quarters · filed 2014-03-17 | $109.12M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | $7.17M 10-K · filed 2014-03-17 | $14.04M 10-Q · filed 2013-08-12 | $20.46M derived: sum of 3 quarters · filed 2014-03-17 | $26.27M derived: sum of 4 quarters · filed 2014-03-17 | $100.76M 10-Q · filed 2012-08-10 | |||||||||
| 2012-03-31 | $6.88M 10-K · filed 2014-03-17 | $13.29M derived: sum of 2 quarters · filed 2014-03-17 | $19.10M derived: sum of 3 quarters · filed 2014-03-17 | $23.76M derived: sum of 4 quarters · filed 2014-03-17 | $93.59M 10-Q · filed 2012-05-09 | |||||||||
| 2011-12-31 | $6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $12.23M derived: sum of 2 quarters · filed 2014-03-17 | $16.89M derived: sum of 3 quarters · filed 2014-03-17 | $20.42M 10-K · filed 2014-03-17 | $86.72M 10-K · filed 2012-03-23 | |||||||||
| 2011-09-30 | $5.81M 10-Q · filed 2012-11-06 | $10.47M derived: sum of 2 quarters · filed 2012-11-06 | $14.01M 10-Q · filed 2012-11-06 | $16.85M derived: sum of 4 quarters · filed 2013-03-12 | $80.30M 10-Q · filed 2011-11-08 | |||||||||
| 2011-06-30 | $4.66M 10-Q · filed 2012-08-10 | $8.20M 10-Q · filed 2012-08-10 | $11.04M derived: sum of 3 quarters · filed 2013-03-12 | $13.64M derived: sum of 4 quarters · filed 2013-03-12 | $74.49M 10-Q · filed 2011-08-11 | |||||||||
| 2011-03-31 | $3.54M 10-Q · filed 2012-05-09 | $6.38M derived: sum of 2 quarters · filed 2013-03-12 | $8.98M derived: sum of 3 quarters · filed 2013-03-12 | $12.29M derived: sum of 4 quarters · filed 2013-03-12 | ||||||||||
| 2010-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $5.45M derived: sum of 2 quarters · filed 2013-03-12 | $8.76M derived: sum of 3 quarters · filed 2013-03-12 | $12.19M 10-K · filed 2013-03-12 | ||||||||||
| 2010-09-30 | $2.60M 10-Q · filed 2011-11-08 | $5.91M derived: sum of 2 quarters · filed 2011-11-08 | $9.34M 10-Q · filed 2011-11-08 | |||||||||||
| 2010-06-30 | $3.31M 10-Q · filed 2011-08-11 | $6.74M 10-Q · filed 2011-08-11 | ||||||||||||
| 2009-12-31 | $19.03M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |